Oruka Therapeutics, Inc. (ORKA) › Operating IncomeOruka Therapeutics, Inc. (ORKA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$9.18M2011: -$7.36M2012: -$4.32M2013: -$6.94M2014: -$9.69M2015: -$11.46M2016: -$16.61M2017: -$18.71M2018: -$8.12M2019: -$5.81M2020: -$9.77M2021: -$19.34M2022: -$10.60M2023: -$7.30M2025: -$122.05M-$122.05M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$122.05M—2023-$7.30M+31.1%2022-$10.60M+45.2%2021-$19.34M-98.0%2020-$9.77M-68.0%2019-$5.81M+28.4%2018-$8.12M+56.6%2017-$18.71M-12.6%2016-$16.61M-45.0%2015-$11.46M-18.2%2014-$9.69M-39.7%2013-$6.94M-60.7%2012-$4.32M+41.3%2011-$7.36M+19.8%2010-$9.18M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share